Natural products as mediators of disease.

Microbiome and metabolome data integration provides insight into health and disease. Transl Res (2017) 0.75

Metabolic Fingerprints from the Human Oral Microbiome Reveal a Vast Knowledge Gap of Secreted Small Peptidic Molecules. mSystems (2017) 0.75

Nonribosomal peptide synthetase biosynthetic clusters of ESKAPE pathogens. Nat Prod Rep (2017) 0.75

Basic local alignment search tool. J Mol Biol (1990) 659.07

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature (1998) 60.62

A core gut microbiome in obese and lean twins. Nature (2008) 52.30

Diversity of the human intestinal microbial flora. Science (2005) 49.64

A human gut microbial gene catalogue established by metagenomic sequencing. Nature (2010) 43.63

Metagenomic analysis of the human distal gut microbiome. Science (2006) 29.76

Host-bacterial mutualism in the human intestine. Science (2005) 26.39

Pattern recognition receptors and inflammation. Cell (2010) 21.05

Topographical and temporal diversity of the human skin microbiome. Science (2009) 15.96

Defining the normal bacterial flora of the oral cavity. J Clin Microbiol (2005) 15.75

Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med (2003) 15.48

Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One (2008) 14.63

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature (2011) 13.53

HMMER web server: interactive sequence similarity searching. Nucleic Acids Res (2011) 13.00

The influence of sex, handedness, and washing on the diversity of hand surface bacteria. Proc Natl Acad Sci U S A (2008) 12.99

Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A (2010) 12.39

An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature (2007) 10.92

Listeria pathogenesis and molecular virulence determinants. Clin Microbiol Rev (2001) 10.41

N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci U S A (1975) 9.24

antiSMASH: rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences. Nucleic Acids Res (2011) 9.22

Diversity, stability and resilience of the human gut microbiota. Nature (2012) 9.09

antiSMASH 3.0-a comprehensive resource for the genome mining of biosynthetic gene clusters. Nucleic Acids Res (2015) 9.05

The human oral microbiome. J Bacteriol (2010) 9.00

Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science (2013) 8.81

Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell (2013) 8.11

antiSMASH 2.0--a versatile platform for genome mining of secondary metabolite producers. Nucleic Acids Res (2013) 8.10

Microbial culturomics: paradigm shift in the human gut microbiome study. Clin Microbiol Infect (2012) 7.97

Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A (2006) 7.77

Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med (2007) 7.75

Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev (2006) 7.72

Intestinal inflammation targets cancer-inducing activity of the microbiota. Science (2012) 7.54

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature (2013) 7.51

Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen (2009) 7.29

Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol (2004) 7.22

Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes. Infect Immun (1987) 6.47

Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science (1999) 6.37

A new antibiotic kills pathogens without detectable resistance. Nature (2015) 6.33

A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature (2004) 6.29

The impact of the gut microbiota on human health: an integrative view. Cell (2012) 6.01

The trypanosomiases. Lancet (2003) 5.96

Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A (2009) 5.86

E-cadherin is the receptor for internalin, a surface protein required for entry of L. monocytogenes into epithelial cells. Cell (1996) 5.82

Human African trypanosomiasis. Lancet (2009) 5.60

Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature (2014) 5.51

Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife (2013) 5.49

Microbial co-occurrence relationships in the human microbiome. PLoS Comput Biol (2012) 5.35

The long-term stability of the human gut microbiota. Science (2013) 5.15

Genetics and assembly line enzymology of siderophore biosynthesis in bacteria. Microbiol Mol Biol Rev (2002) 5.12

Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A (2011) 4.91

Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc Natl Acad Sci U S A (2011) 4.85

Targeting virulence: a new paradigm for antimicrobial therapy. Nat Chem Biol (2007) 4.83

The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages. Proc Natl Acad Sci U S A (2000) 4.82

Burn wound infections. Clin Microbiol Rev (2006) 4.81

Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med (2011) 4.78

Tuberculosis. N Engl J Med (2013) 4.75

Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol (2013) 4.60

Temporal dynamics of the human vaginal microbiota. Sci Transl Med (2012) 4.58

Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science (2006) 4.58

Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc Natl Acad Sci U S A (2011) 4.53

Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis (2002) 4.43

Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell (2014) 4.25

Specificity prediction of adenylation domains in nonribosomal peptide synthetases (NRPS) using transductive support vector machines (TSVMs). Nucleic Acids Res (2005) 4.15

Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran. Chest (2009) 4.11

Cultivating the uncultured. Proc Natl Acad Sci U S A (2002) 4.03

Enterobactin: an archetype for microbial iron transport. Proc Natl Acad Sci U S A (2003) 3.94

Identification of a Mycobacterium tuberculosis gene cluster encoding the biosynthetic enzymes for assembly of the virulence-conferring siderophore mycobactin. Chem Biol (1998) 3.89

The expanded biology of serotonin. Annu Rev Med (2009) 3.87

The interaction between bacteria and bile. FEMS Microbiol Rev (2005) 3.86

Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol (2012) 3.84

Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog (2010) 3.75

Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med (2013) 3.65

Role of the microbiota in immunity and inflammation. Cell (2014) 3.43

Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol (2008) 3.37

Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med (2005) 3.36

Microbial interactions: from networks to models. Nat Rev Microbiol (2012) 3.28

Genomic mining for Aspergillus natural products. Chem Biol (2006) 3.22

Discovery of a widely distributed toxin biosynthetic gene cluster. Proc Natl Acad Sci U S A (2008) 3.20

NRPSpredictor2--a web server for predicting NRPS adenylation domain specificity. Nucleic Acids Res (2011) 3.19

Clinical practice. Uncomplicated urinary tract infection. N Engl J Med (2012) 3.10

Human commensals producing a novel antibiotic impair pathogen colonization. Nature (2016) 3.03

The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med (2015) 3.01

A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics. Cell (2014) 2.97

Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect Immun (2011) 2.87

Rethinking 'secondary' metabolism: physiological roles for phenazine antibiotics. Nat Chem Biol (2006) 2.86

The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol (2012) 2.83

Skin microbiota: a source of disease or defence? Br J Dermatol (2008) 2.81

Dynamics of nasopharyngeal colonization by potential respiratory pathogens. J Antimicrob Chemother (2002) 2.78

Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol (2012) 2.75

p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease. Nephrol Dial Transplant (2010) 2.66

Methods of integrating data to uncover genotype-phenotype interactions. Nat Rev Genet (2015) 2.66

Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus. Cell Host Microbe (2010) 2.64

Insights into secondary metabolism from a global analysis of prokaryotic biosynthetic gene clusters. Cell (2014) 2.59

Mycobacterial toxin induces analgesia in buruli ulcer by targeting the angiotensin pathways. Cell (2014) 2.51

Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. J Infect Dis (2005) 2.50

Natural Products as Sources of New Drugs from 1981 to 2014. J Nat Prod (2016) 2.47

How pathogenic bacteria evade mammalian sabotage in the battle for iron. Nat Chem Biol (2006) 2.45

The oral microbiome in health and disease. Pharmacol Res (2012) 2.40

The multiple signaling systems regulating virulence in Pseudomonas aeruginosa. Microbiol Mol Biol Rev (2012) 2.36

Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int J Syst Evol Microbiol (2002) 2.35

Mutational analysis of the group A streptococcal operon encoding streptolysin S and its virulence role in invasive infection. Mol Microbiol (2005) 2.30

Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep (2013) 5.38

ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell (2011) 4.26

A monovalent streptavidin with a single femtomolar biotin binding site. Nat Methods (2006) 3.89

Mass spectral molecular networking of living microbial colonies. Proc Natl Acad Sci U S A (2012) 3.56

Discovery of a widely distributed toxin biosynthetic gene cluster. Proc Natl Acad Sci U S A (2008) 3.20

PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression. Nature (2010) 2.91

Single cell genome amplification accelerates identification of the apratoxin biosynthetic pathway from a complex microbial assemblage. PLoS One (2011) 2.73

Translating metabolic exchange with imaging mass spectrometry. Nat Chem Biol (2009) 2.47

A sliding docking interaction is essential for sequential and processive phosphorylation of an SR protein by SRPK1. Mol Cell (2008) 2.29

Biosynthetic origin of natural products isolated from marine microorganism-invertebrate assemblages. Proc Natl Acad Sci U S A (2008) 2.23

MS/MS networking guided analysis of molecule and gene cluster families. Proc Natl Acad Sci U S A (2013) 2.12

Proteasomal protein degradation in Mycobacteria is dependent upon a prokaryotic ubiquitin-like protein. J Biol Chem (2008) 2.12

A mass spectrometry-guided genome mining approach for natural product peptidogenomics. Nat Chem Biol (2011) 2.05

Imaging mass spectrometry in microbiology. Nat Rev Microbiol (2011) 2.04

Imaging mass spectrometry of intraspecies metabolic exchange revealed the cannibalistic factors of Bacillus subtilis. Proc Natl Acad Sci U S A (2010) 1.90

Convergence of isoprene and polyketide biosynthetic machinery: isoprenyl-S-carrier proteins in the pksX pathway of Bacillus subtilis. Proc Natl Acad Sci U S A (2006) 1.80

Direct cloning and refactoring of a silent lipopeptide biosynthetic gene cluster yields the antibiotic taromycin A. Proc Natl Acad Sci U S A (2014) 1.78

Molecular basis for chloronium-mediated meroterpene cyclization: cloning, sequencing, and heterologous expression of the napyradiomycin biosynthetic gene cluster. J Biol Chem (2007) 1.71

Biosynthesis of the thiazole moiety of thiamin pyrophosphate (vitamin B1). Biochemistry (2003) 1.70

Molecular networking as a dereplication strategy. J Nat Prod (2013) 1.57

Interspecies interactions stimulate diversification of the Streptomyces coelicolor secreted metabolome. MBio (2013) 1.56

Codon randomization for rapid exploration of chemical space in thiopeptide antibiotic variants. Chem Biol (2012) 1.55

Microbial metabolic exchange--the chemotype-to-phenotype link. Nat Chem Biol (2011) 1.55

Deconvolution and database search of complex tandem mass spectra of intact proteins: a combinatorial approach. Mol Cell Proteomics (2010) 1.53

Saccharomyces cerevisiae THI4p is a suicide thiamine thiazole synthase. Nature (2011) 1.50

Visualizing the spatial distribution of secondary metabolites produced by marine cyanobacteria and sponges via MALDI-TOF imaging. Mol Biosyst (2008) 1.47

Interkingdom metabolic transformations captured by microbial imaging mass spectrometry. Proc Natl Acad Sci U S A (2012) 1.46

The evolving field of imaging mass spectrometry and its impact on future biological research. J Mass Spectrom (2011) 1.43

Enzymatic synthesis of resorcylic acid lactones by cooperation of fungal iterative polyketide synthases involved in hypothemycin biosynthesis. J Am Chem Soc (2010) 1.41

Dereplication and de novo sequencing of nonribosomal peptides. Nat Methods (2009) 1.41

Reconstitution of a new cysteine biosynthetic pathway in Mycobacterium tuberculosis. J Am Chem Soc (2005) 1.40

Genomic insights into the physiology and ecology of the marine filamentous cyanobacterium Lyngbya majuscula. Proc Natl Acad Sci U S A (2011) 1.40

Structure of oxalate decarboxylase from Bacillus subtilis at 1.75 A resolution. Biochemistry (2002) 1.39

Interpretation of tandem mass spectra obtained from cyclic nonribosomal peptides. Anal Chem (2009) 1.37

A phosphopantetheinylating polyketide synthase producing a linear polyene to initiate enediyne antitumor antibiotic biosynthesis. Proc Natl Acad Sci U S A (2008) 1.36

Structural and mechanistic studies on ThiO, a glycine oxidase essential for thiamin biosynthesis in Bacillus subtilis. Biochemistry (2003) 1.35

Top-down mass spectrometry on low-resolution instruments: characterization of phosphopantetheinylated carrier domains in polyketide and non-ribosomal biosynthetic pathways. Bioorg Med Chem Lett (2007) 1.33

Synergistic allelochemicals from a freshwater cyanobacterium. Proc Natl Acad Sci U S A (2010) 1.33

Expansion of the mycobacterial "PUPylome". Mol Biosyst (2009) 1.31

Bacterial biosynthesis and maturation of the didemnin anti-cancer agents. J Am Chem Soc (2012) 1.29

Marinopyrrole A target elucidation by acyl dye transfer. J Am Chem Soc (2009) 1.26

Clostridiolysin S, a post-translationally modified biotoxin from Clostridium botulinum. J Biol Chem (2010) 1.25

Primer on agar-based microbial imaging mass spectrometry. J Bacteriol (2012) 1.22

Incorporation of nonmethyl branches by isoprenoid-like logic: multiple beta-alkylation events in the biosynthesis of myxovirescin A1. Chem Biol (2007) 1.21

Imaging mass spectrometry of natural products. Nat Prod Rep (2009) 1.20

Underestimated biodiversity as a major explanation for the perceived rich secondary metabolite capacity of the cyanobacterial genus Lyngbya. Environ Microbiol (2011) 1.18

Acyltransferase mediated polyketide release from a fungal megasynthase. J Am Chem Soc (2009) 1.18

The Bacillus subtilis cannibalism toxin SDP collapses the proton motive force and induces autolysis. Mol Microbiol (2012) 1.17

Palmyramide A, a cyclic depsipeptide from a Palmyra Atoll collection of the marine cyanobacterium Lyngbya majuscula. J Nat Prod (2010) 1.16

Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis. PLoS One (2010) 1.15

Bioactivity-guided genome mining reveals the lomaiviticin biosynthetic gene cluster in Salinispora tropica. Chembiochem (2013) 1.15

Biosynthesis of the beta-amino acid moiety of the enediyne antitumor antibiotic C-1027 featuring beta-amino acyl-S-carrier protein intermediates. J Am Chem Soc (2005) 1.14

Characterization of the formation of the pyrrole moiety during clorobiocin and coumermycin A1 biosynthesis. Biochemistry (2005) 1.13

Glycogenomics as a mass spectrometry-guided genome-mining method for microbial glycosylated molecules. Proc Natl Acad Sci U S A (2013) 1.12

Capturing bacterial metabolic exchange using thin film desorption electrospray ionization-imaging mass spectrometry. Anal Chem (2010) 1.12

Methicillin-resistant Staphylococcus aureus bacterial nitric-oxide synthase affects antibiotic sensitivity and skin abscess development. J Biol Chem (2013) 1.11

Microbial metabolic exchange in 3D. ISME J (2013) 1.11

The spectral networks paradigm in high throughput mass spectrometry. Mol Biosyst (2012) 1.11

Significant natural product biosynthetic potential of actinorhizal symbionts of the genus frankia, as revealed by comparative genomic and proteomic analyses. Appl Environ Microbiol (2011) 1.10

Microbial competition between Bacillus subtilis and Staphylococcus aureus monitored by imaging mass spectrometry. Microbiology (2011) 1.09

Mass spectrometry of natural products: current, emerging and future technologies. Nat Prod Rep (2014) 1.09

Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry. J Biol Chem (2012) 1.08

Connecting chemotypes and phenotypes of cultured marine microbial assemblages by imaging mass spectrometry. Angew Chem Int Ed Engl (2011) 1.07

Thiamin biosynthesis in Bacillus subtilis: structure of the thiazole synthase/sulfur carrier protein complex. Biochemistry (2004) 1.07

Biosynthetic multitasking facilitates thalassospiramide structural diversity in marine bacteria. J Am Chem Soc (2013) 1.06

Formation of the dimethylbenzimidazole ligand of coenzyme B(12) under physiological conditions by a facile oxidative cascade. Org Lett (2003) 1.05

Cytotoxic veraguamides, alkynyl bromide-containing cyclic depsipeptides from the marine cyanobacterium cf. Oscillatoria margaritifera. J Nat Prod (2011) 1.05

Kinetic isotope effect studies on the de novo rate of chromophore formation in fast- and slow-maturing GFP variants. Biochemistry (2008) 1.04

A novel Entamoeba histolytica cysteine proteinase, EhCP4, is key for invasive amebiasis and a therapeutic target. J Biol Chem (2010) 1.03

Enzymatic resistance to the lipopeptide surfactin as identified through imaging mass spectrometry of bacterial competition. Proc Natl Acad Sci U S A (2012) 1.02

Metabolic profiling directly from the Petri dish using nanospray desorption electrospray ionization imaging mass spectrometry. Anal Chem (2013) 1.01

Substrate specificity of the adenylation enzyme SgcC1 involved in the biosynthesis of the enediyne antitumor antibiotic C-1027. J Biol Chem (2006) 1.00

Lipophilic mediated assays for beta-hematin inhibitors. Comb Chem High Throughput Screen (2010) 0.99

Probing marine natural product defenses with DESI-imaging mass spectrometry. Proc Natl Acad Sci U S A (2009) 0.99

Real-time metabolomics on living microorganisms using ambient electrospray ionization flow-probe. Anal Chem (2013) 0.98

Temporal dynamics of natural product biosynthesis in marine cyanobacteria. Proc Natl Acad Sci U S A (2011) 0.98

Molecular analysis of model gut microbiotas by imaging mass spectrometry and nanodesorption electrospray ionization reveals dietary metabolite transformations. Anal Chem (2012) 0.97

Automated querying and identification of novel peptides using MALDI mass spectrometric imaging. J Proteome Res (2011) 0.97

Characterization of a new tailoring domain in polyketide biogenesis: the amine transferase domain of MycA in the mycosubtilin gene cluster. J Am Chem Soc (2005) 0.94

Imaging mass spectrometry and genome mining via short sequence tagging identified the anti-infective agent arylomycin in Streptomyces roseosporus. J Am Chem Soc (2011) 0.94

Protein assembly line components in prodigiosin biosynthesis: characterization of PigA,G,H,I,J. J Am Chem Soc (2006) 0.94

Genome-wide high-throughput mining of natural-product biosynthetic gene clusters by phage display. Chem Biol (2007) 0.92

Combining Mass Spectrometric Metabolic Profiling with Genomic Analysis: A Powerful Approach for Discovering Natural Products from Cyanobacteria. J Nat Prod (2015) 0.91

Automated genome mining of ribosomal peptide natural products. ACS Chem Biol (2014) 0.91

The bacterial chemical repertoire mediates metabolic exchange within gut microbiomes. Curr Opin Microbiol (2011) 0.91

Investigating nonribosomal peptide and polyketide biosynthesis by direct detection of intermediates on >70 kDa polypeptides by using Fourier-transform mass spectrometry. Chembiochem (2006) 0.91

Characterization of the bacterial community of the chemically defended Hawaiian sacoglossan Elysia rufescens. Appl Environ Microbiol (2013) 0.90

Observing the invisible through imaging mass spectrometry, a window into the metabolic exchange patterns of microbes. J Proteomics (2012) 0.88

FT-ICR-MS characterization of intermediates in the biosynthesis of the α-methylbutyrate side chain of lovastatin by the 277 kDa polyketide synthase LovF. Biochemistry (2010) 0.88

Tools for the Microbiome: Nano and Beyond. ACS Nano (2015) 0.87

A bacterial pathogen co-opts host plasmin to resist killing by cathelicidin antimicrobial peptides. J Biol Chem (2012) 0.87

Phosphonopeptide K-26 biosynthetic intermediates in Astrosporangium hypotensionis. Chem Commun (Camb) (2006) 0.87

Genetic basis for the biosynthesis of the pharmaceutically important class of epoxyketone proteasome inhibitors. ACS Chem Biol (2013) 0.86

Mechanistic studies on pyridoxal phosphate synthase: the reaction pathway leading to a chromophoric intermediate. J Am Chem Soc (2008) 0.86

Multiplex de novo sequencing of peptide antibiotics. J Comput Biol (2011) 0.86

Microbiota of healthy corals are active against fungi in a light-dependent manner. ACS Chem Biol (2014) 0.85